| 1 |
35209071 | Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer. | 2022 Feb 14 |
1 |
| 2 |
35340325 | Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage. | 2022 Apr |
8 |
| 3 |
35405577 | HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. | 2022 May |
3 |
| 4 |
33234363 | Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. | 2021 Jan |
2 |
| 5 |
34129726 | Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway. | 2021 Jun 15 |
1 |
| 6 |
34191749 | Correction for: miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway. | 2021 Jun 30 |
1 |
| 7 |
34589145 | Nanoscale Au@SiO2-drug/VEGF as an in vivo probe for osteosarcoma diagnosis and therapy. | 2021 Nov |
6 |
| 8 |
34697389 | REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression. | 2021 Oct |
2 |
| 9 |
34812943 | Intercalated doxorubicin acting as stimulator of PbS photocathode for probing DNA-protein interactions. | 2021 Nov 23 |
2 |
| 10 |
34880998 | Aptamer-modified DNA tetrahedra-gated metal-organic framework nanoparticle carriers for enhanced chemotherapy or photodynamic therapy. | 2021 Nov 10 |
4 |
| 11 |
31903460 | Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma. | 2020 Mar 7 |
1 |
| 12 |
32592377 | Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line. | 2020 Jun 1 |
2 |
| 13 |
32860839 | Doxorubicin exhibits strong and selective association with VEGF Pu22 G-quadruplex. | 2020 Dec |
7 |
| 14 |
31389949 | Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H2O2 responsive and oxygen-producing nanohybrids. | 2019 Aug 7 |
2 |
| 15 |
28362176 | Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line. | 2018 Mar |
1 |
| 16 |
29465130 | Targeted VEGF-triggered release of an anti-cancer drug from aptamer-functionalized metal-organic framework nanoparticles. | 2018 Mar 8 |
2 |
| 17 |
29774068 | Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy. | 2018 |
1 |
| 18 |
29805519 | The effects of doxorubicin-loaded liposomes on viability, stem cell surface marker expression and secretion of vascular endothelial growth factor of three-dimensional stem cell spheroids. | 2018 Jun |
3 |
| 19 |
32254698 | Design and self-assembly of albumin nanoclusters as a dynamic-covalent targeting co-delivery and stimuli-responsive controlled release platform. | 2018 Nov 14 |
1 |
| 20 |
28652734 | Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. | 2017 |
1 |
| 21 |
28684738 | Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. | 2017 Jul 6 |
1 |
| 22 |
28923539 | Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO2@LDH for anti-neuroblastoma therapy. | 2017 Nov |
2 |
| 23 |
29182025 | VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy. | 2017 Nov |
7 |
| 24 |
27191965 | Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy. | 2016 Jun 8 |
2 |
| 25 |
29363936 | Doxorubicin Hydrochloride-Loaded Mesoporous Silica Nanoparticles Inhibit Non-Small Cell Lung Cancer Metastasis by Suppressing VEGF-Mediated Angiogenesis. | 2016 Nov |
1 |
| 26 |
25796551 | Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma? | 2015 May |
1 |
| 27 |
25818803 | Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. | 2015 Mar 30 |
1 |
| 28 |
26199906 | Downregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells. | 2015 Summer |
1 |
| 29 |
25275022 | Differential expression of VEGF and IL-1alpha after photodynamic treatment in combination with doxorubicin or taxotere. | 2014 Oct |
2 |
| 30 |
25304380 | Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis. | 2014 Dec 28 |
2 |
| 31 |
25338584 | [Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line]. | 2014 Oct |
2 |
| 32 |
22684860 | Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. | 2013 Jan 1 |
1 |
| 33 |
23765166 | Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase /protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line. | 2013 Aug |
1 |
| 34 |
23959856 | Tumor cells upregulate normoxic HIF-1α in response to doxorubicin. | 2013 Oct 15 |
1 |
| 35 |
24217648 | Doxorubicin caused apoptosis of mesenchymal stem cells via p38, JNK and p53 pathway. | 2013 |
1 |
| 36 |
22145922 | Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. | 2012 Mar |
1 |
| 37 |
22394685 | The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. | 2012 Mar 6 |
1 |
| 38 |
22479438 | Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery. | 2012 |
1 |
| 39 |
22510476 | miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. | 2012 Jun |
2 |
| 40 |
20490863 | Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression. | 2011 Mar |
1 |
| 41 |
21362217 | [VEGF shRNA enhances the sensitivity of multidrug-resistant leukemia cells to anticancer agent]. | 2011 Feb |
3 |
| 42 |
20460382 | Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. | 2010 Jul 16 |
1 |
| 43 |
20939432 | Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors. | 2010 |
2 |
| 44 |
21303748 | Overexpression of vascular endothelial growth factor 165 (VEGF165) protects cardiomyocytes against doxorubicin-induced apoptosis. | 2010 Dec |
1 |
| 45 |
19794965 | A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. | 2009 Oct |
3 |
| 46 |
17912235 | RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. | 2008 Jan |
4 |
| 47 |
18471962 | Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells. | 2008 Sep 18 |
1 |
| 48 |
18494554 | A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. | 2008 May 20 |
2 |
| 49 |
18697197 | Chemotherapeutic drugs and human tumor cells cytokine network. | 2008 Nov 1 |
1 |
| 50 |
18854653 | Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy. | 2008 Oct |
1 |